Erectile Dysfunction

141 days ago

Futura Medical: producing a rubbish product won’t give your share price a stiffy

It was in August 2023 with shares in Futura Medical (FUM) at 52p t buy that Lucian Miers volunteered to do some on the ground research into Eroxon, its “treatment” for Erectile Dysfunction. It is not as if Lucian, like many grandfathers of his age, needs to use Eroxon, he checked out how it was selling in Boots and the catastrophic online reviews and concluded that if customers do not think a product works they will not reorder and the business is screwed. Today the shares are 18.5p after a massive lack of profits warning.

364 days ago

Chatroom warriors celebrate as Lucian Miers stiffed (geddit?) by Futura Medical trading statement

Before they celebrate too much the gerbils should realise that even though the shares are up by 34% today at 37.1p the bard of the Boleyn is still way ahead on is short bet. But perhaps the trading statement marks a turning point for this producer of Eroxon, a treatment for Erectile Dysfunction which most customers appear to think is useless.

676 days ago

Tom Winnifrith Bearcast: By Jove, Lucian Miers is bang on the money

In today’s podcast I discuss Alien Metals (UFO), Hydrogen Utopia (HUI), Optibiotix (OPTI) and an email exchange with Steve O’Hara, inflation, Iconic (ICON), Futura Medical (FUM), Haleon (HLN) and Lucian’s research into curing erectile dysfunction among men of his age.